HomeHIV/Aids
HIV/Aids
Bone marrow transplant ‘cures’ French HIV patient
A patient at the Sainte-Marguerite Hospital in Marseille could be the first case of someone being cured of HIV in France – thanks to...
Minister says SA will reach HIV treatment goals despite aid cuts
US President Donald Trump’s aid cuts will not derail SA’s goal of providing treatment to an additional 1.1m HIV patients by December, Health Minister...
More work vital for HIV campaign’s success, say experts
Amid major disruptions caused by aid cuts from the United States Government, the National Department of Health aims to enrol an additional 1.1m more...
Baby boys from KZN hold hope for HIV cure
Twenty-three years ago, 11-year-old Nkosi Johnson stepped on to the stage at the International Aids Conference in Durban, and addressed an audience of 60m....
Mashatile promises patients six-month supply of ARVs
Deputy President Paul Mashatile has announced that the government will provide HIV-positive patients with a six-month supply of antiretroviral (ARV) medication, a notable boost...
Pepfar boss to resign before Trump takes office
Ambassador John Nkengasong, head of the US President’s Emergency Plan for Aids Relief (Pepfar), says that because he is a political appointee, he will be...
Where we stand with the HIV epidemic
It’s 40 years since Aids was first identified. Major strides have been made since the spread of the virus reached epidemic proportions in 1995...
SA women could have three-monthly anti-HIV ring by 2026
A flexible silicone ring that slowly releases antiretrovirals is one of just two long-acting HIV prevention products registered for use in South Africa, but...
Probe after patients get HIV from organ transplants
Brazilian health officials are scrambling to explain how six transplant patients in the country’s well-regarded public health system received organs infected with HIV –...
Gilead in talks with SAHPRA to register twice-yearly anti-HIV jab
Gilead Sciences, which makes the six-monthly anti-HIV injection, has approached the SA Health Products Regulatory Authority (SAHPRA) to discuss how to get the shot registered...
Pepfar chief pushes for extension of programme
USAids relief programme head John Nkengasong is committed to persuading Congress to return to granting a five-year reauthorisation of the programme, he said in...
Gilead inks deal for generic HIV drug supply to low-income nations
Gilead Sciences has granted royalty-free licences to six generic drug manufacturers to make and sell cheaper copycat versions of its HIV prevention medicine in...
African drug makers urged to adopt a regional approach
US global Aids co-ordinator John Nkengasong has called on African pharmaceutical companies to investigate the possibility of a regional manufacturing approach, to take advantage of...
Western Cape youngsters drive province's HIV spike
Findings of an extensive survey released by the Human Sciences Research Council last week include that sexual debut before the age of 15 –...
Survey shows HIV rates soaring in Mpumalanga
Nearly 900 000 people in Mpumalanga (or 17.4% of the population) are HIV positive, giving it the dubious title of province with the highest infection in the country, according...
US to buy African-made ARVs for Pepfar programme
America is throwing its weight behind African production of antiretrovirals, with the US President’s Emergency Plan for Aids Relief programme (Pepfar) committing to buying...
HIV drug trial success triumph for Professor Bekker
In a fitting acknowledgement last week at the International Aids Conference in Munich, Germany, Cape Town’s Professor Linda-Gail Bekker received a standing ovation when...